IL18 and Alzheimer disease: As IL18 can potentially regulate both type 1 and type 2 cytokine productions, it makes it a prominent candidate to control the switch between acute and chronic AD, which are characterized by type 2 and type 1 cytokines, respectively (Langan et al., 2020).